EMD Chemicals Inc.

“The Pink Sheet” regularly presents commentary and perspective on key business deals. Here is a summary of the most noteworthy transactions that occurred between Sept. 20 and Sept. 26 . Merck KGAA/Sig

With a painful two-year restructuring behind it - and its pharmaceutical franchise officially on the mend - German drug and chemicals group Merck KGAA now plans to boost its biopharma lab business